Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/5/09 → 6/30/11 |
Financiación
- Novartis (domestic): 3.843,00 US$
A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants
- Greenberg, Richard (PI)